WJNS  Vol.4 No.1 , February 2014
Neuroprotective effect of panax notoginseng saponins and its main components
ABSTRACT

Stroke is the third leading cause of death and the first cause of adult disability in industrial countries [1]. It is charicaterized by hemiplegia, hemianopsia, aphasia, mouth askew and sever sequelae. It is considered that an ischemic disease without any specific treatment method and few effective drugs such as tPA (human tissue-type plasminogen activator) and Edarovone with specific therapeutic window will cause a lot of disadvantages if being used inaccurate. Root of Panax notoginseng (PN) which is one of traditional Chinese medicines (TCMs), was first found in “Shennong’s Classic of Materia Medica” around 200 AD. Panax notogineng saponins(PNS) is a multi-components mixture containing ginseng and saponins as the most important bioactive components which are commonly used in clinical treatment. Also, ginseng and saponins form the main components of many herbal medicines in the market, e.g., Xueshuantong injection [2], Xuesaitong injection [3], Xuesaitong soft capsule [4] and so on. The main monomers of Panax notoginseng saponins (PNS) are Ginsenoside-Rb1, Gensenoside-Rg1, Gensenoside-Re, Gensenoside-Rd and Panax notoginseng saponins-R1 [5]. In this review, we found some important points as well as shortcomings that require special consideration. We therefore highlighted the advances in neuro-protection of PNS and its main monomers in the area of experimental research.


Cite this paper
Wang, X. , Wang, S. and Hu, L. (2014) Neuroprotective effect of panax notoginseng saponins and its main components. World Journal of Neuroscience, 4, 12-17. doi: 10.4236/wjns.2014.41002.
References
[1]   Belayev, L., Khoutorova, L., Atkins, K.D. and Bazan, N.G. (2009) Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke, 40, 3121-3126.
http://dx.doi.org/10.1161/STROKEAHA.109.555979

[2]   Gao, L., Zhao, H., Liu, Q., Song, J., Xu, C., Liu, P., Gong, W., Wang, R., Liu, K.J. and Luo, Y. (2012) Improvement of hematoma absorption and neurological function in patients with acute intracerebral hemorrhage treated with Xueshuantong. Journal of the Neurological Sciences, 15, 236-240. http://dx.doi.org/10.1016/j.jns.2012.09.028

[3]   Ai, W.B., Chen, Y.H. and Yang, Q.J. (2004) Clinical observation on effect of xuesaitong injection as auxiliary treatment of severe craniocerebral injury. Zhongguo Zhong Xi Yi Jie He Za Zhi, 24, 213-215.

[4]   Zhong, S.Q., Sun, L.J., Yan, Y.Z., Sun, Y.Q. and Zhong, Y.Y. (2005) Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction. Chinese Journal of Integrative Medicine, 11, 128-131.
http://dx.doi.org/10.1007/BF02836469

[5]   Li, S.P., Qiao, C.F., Chen, Y.W., Zhao, J., Cui, X.M., Zhang, Q.W., Liu, X.M. and Hu, D.J. (2013) A novel strategy with standardized reference extract qualification and single compound quantitative evaluation for quality control of Panax notoginseng used as a functional food. Journal of Chromatography A, 1313, 303-307.
http://dx.doi.org/10.1016/j.chroma.2013.07.025

[6]   Nie, Y.X., Wang, D. and Zhang, X. (2006) Effect of panax notoginseng saponins injection on brain edema in intracerebral hemorrhage rats. Zhongguo Zhong Xi Yi Jie He Za Zhi, 26, 922-925.

[7]   Chen, X., Zhou, M., Li, Q., Yang, J., Zhang, Y., Zhang, D., Kong, S., Zhou, D. and He, L. (2008) Sanchi for acute ischaemic stroke. Cochrane Database of Systematic Reviews, 4.
http://dx.doi.org/10.1002/14651858.CD006305.pub2

[8]   Yao, X.H. and Li, X.J. (2002) Protective effects and its mechanism of panaxatriol saponins isolated from Panax notoginseng on cerebralischemia. Zhongguo Zhong Yao Za Zhi, 27, 371-373.

[9]   Wu, J.X. and Sun, J.J. (1992) Comparative effects of Panax notoginseng saponins, verapamil, and norepinephrine on cerebral circulation inanesthetized rats and rabbits. Zhongguo Yao Li Xue Bao, 13, 520-523.

[10]   Ma, L., Xiao, P., Guo, B., Wu, J., Liang, F. and Dong, S. (1999) Cerebral protective effects of some compounds isolated from traditional Chinese herbs. Zhongguo Zhong Yao Za Zhi, 24, 238-239, 256-inside back cover.

[11]   Ma, L.Y., Xiao, P.G., Liang, F.Q., Chi, M.G. and Dong, S.J. (1997) Effect of saponins of Panax notoginseng on synaptosomal 45Ca uptake. Zhongguo Yao Li Xue Bao, 18, 213-215.

[12]   Han, J., Hu, W. and Sun, Z. (1999) Effect of Panax notoginseng saponin on Ca2+, CaM in craniocerebral injury. Zhongguo Zhong Xi Yi Jie He Za Zhi, 19, 227-229.

[13]   Tang, Y.H., Zhang, S.P., Liang, Y. and Deng, C.Q. (2007) Effects of Panax notoginseng saponins on mRNA expressions of interleukin-1 beta, its correlative factors andcysteinyl-aspartate specific protease after cerebral ischemia-reperfusion in rats. Zhong Xi Yi Jie He Xue Bao, 5, 328-332. http://dx.doi.org/10.3736/jcim20070319

[14]   Li, H., Deng, C.Q., Chen, B.Y., Zhang, S.P., Liang, Y. and Luo, X.G. (2009) Total saponins of Panax notoginseng modulate the expression of caspases and attenuate apoptosis in ratsfollowing focal cerebral ischemia-reperfusion. Journal of Ethnopharmacology, 30, 412-418.
http://dx.doi.org/10.1016/j.jep.2008.10.042

[15]   Zhu, L.Q., Fan, J.P., Huang, Q.F., Sun, S.L., Gao, Y., Zou, Y.H., Zhang, Z., He, L.Y.and Zheng, H. (2003) Study on the anti-apopotosis induced by hypoxia/hypoglycemia and reoxygenation of panax notoginseng saponins in cultured rat hippocampal neurons. Zhongguo Zhong Yao Za Zhi, 28, 52-55.

[16]   Jiang, K.Y. and Qian, Z.N. (1995) Effects of Panax notoginseng saponins on posthypoxic cell damage of neurons in vitro. Zhongguo Yao Li Xue Bao, 16, 399-402.

[17]   Lee, S.H., Jung, B.H., Kim, S.Y., Lee, E.H. and Chung, B.C. (2006) The antistress effect of ginseng total saponin and ginsenoside Rg3 and Rb1 evaluated by brain polyamine levelunder immobilization stress. Pharmacological Research, 54, 46-49.
http://dx.doi.org/10.1016/j.phrs.2006.02.001

[18]   Deng, H.L. and Zhang, J.T. (1991) Anti-lipid peroxilative effect of ginsenoside Rb1 and Rg1. Chinese Medical Journal (English Edition), 104, 395-398.

[19]   Yoshikawa, T., Akiyoshi, Y., Susumu, T., Tokado, H., Fukuzaki, K., Nagata, R., Samukawa, K., Iwao, H. and Kito, G. (2008) Ginsenoside Rb1 reduces neurodegeneration in the peri-infarct area of a thromboembolic stroke model in non-human primates. Journal of Pharmacological Sciences, 107, 32-40.
http://dx.doi.org/10.1254/jphs.FP0071297

[20]   Mook-Jung, I., Hong, H.S., Boo, J.H., Lee, K.H., Yun, S.H., Cheong, M.Y., Joo, I., Huh, K. and Jung, M.W. (2001) Ginsenoside Rb1 and Rg1 improve spatial learning and increase hippocampal synaptophysin level in mice. Journal of Neuroscience Research, 63, 509-515.
http://dx.doi.org/10.1002/jnr.1045

[21]   Lee, J.S., Song, J.H., Sohn, N.W. and Shin, J.W. (2012) Inhibitory Effects of Ginsenoside Rb1 on Neuroinflammation Following Systemic Lipopolysaccharide Treatment inMice. Phytotherapy Research, 27, 1270-1276.
http://dx.doi.org/10.1002/ptr.4852

[22]   Yuan, Q.L., Yang, C.X., Xu, P., Gao, X.Q., Deng, L., Chen, P., Sun, Z.L. and Chen, Q.Y. (2007) Neuroprotective effects of ginsenoside Rb1 on transient cerebral ischemia in rats. Brain Research, 1167, 1-12.
http://dx.doi.org/10.1016/j.brainres.2007.06.024

[23]   Wen, T.C., Yoshimura, H., Matsuda, S., Lim, J.H. and Sakanaka, M. (1996) Ginseng root prevents learning disability and neuronal loss in gerbils with 5-minute forebrain ischemia. Acta Neuropathologica, 91, 15-22.
http://dx.doi.org/10.1007/s004010050387

[24]   Salim, K.N., McEwen, B.S. and Chao, H.M. (1997) Ginsenoside Rb1 regulates ChAT, NGF and trkA mRNA expression in the rat brain. Molecular Brain Research, 47, 177-182. http://dx.doi.org/10.1016/S0169-328X(97)00042-9

[25]   Benishin, C.G. (1992) Actions of ginsenoside Rb1 on choline uptake in central cholinergic nerve endings. Neurochemistry International, 21, 1-5.
http://dx.doi.org/10.1016/0197-0186(92)90061-U

[26]   Cheng, Y., Shen, L.H. and Zhang. J.T. (2005) Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacologica Sinica, 26, 143-149.
http://dx.doi.org/10.1111/j.1745-7254.2005.00034.x

[27]   Liu, L., Hoang-Gia, T., Wu, H., Lee, M.R., Gu, L., Wang, C., Yun, B.S., Wang, Q., Ye, S. and Sung, C.K. (2011) Ginsenoside Rb1 improves spatial learning and memory by regulation of cell genesis in the hippocampalsubregions of rats. Brain Research, 1382, 147-154.
http://dx.doi.org/10.1016/j.brainres.2011.01.051

[28]   Yang, C.X., Liu, J.X., Sun, Z.L., Gao, X.Q., Deng, L. and Yuan, Q.L. (2008) Effects of Ginsenoside RB1 on neural cell apoptosis and expressions of Bcl-2 and Bax in rats followingsubjected to cerebral ischemia-reperfusion. Sichuan Da Xue Xue Bao Yi Xue Ban, 39, 214-217.

[29]   Lin, Z.Y., Chen, L.M., Zhang, J., Pan, X.D., Zhu, Y.G., Ye, Q.Y., Huang, H.P. and Chen, X.C. (2012) Ginsenoside Rb1 selectively inhibits the activity of L-type voltage-gated calcium channels in cultured rathippocampal neurons. Acta Pharmacologica Sinica, 33, 438-44.
http://dx.doi.org/10.1038/aps.2011.181

[30]   Jiang, X.Y., Zhang, J.T. and Shi, C.Z. (1996) Mechanism of action of ginsenoside Rb1 in decreasing intracellular Ca2+. Yao Xue Xue Bao, 31, 321-326.

[31]   Xue, J.F., Liu, Z.J., Hu, J.F., Chen, H., Zhang, J.T. and Chen, N.H. (2006) Ginsenoside Rb1 promotes neurotransmitter release by modulating phosphorylation of synapsins through acAMP-dependent protein kinase pathway. Brain Research, 1106, 91-98.
http://dx.doi.org/10.1016/j.brainres.2006.05.106

[32]   Song, J.Q., Chen, X.C., Zhang, J., Huang, T.W., Zeng, Y.Q., Shen, J. and Chen, L.M. (2008) JNK/p38 MAPK involves in ginsenoside Rb1 attenuating beta-amyloid peptide (25-35) -induced tau proteinhyperphosphorylation in embryo rat cortical neurons. Yao Xue Xue Bao, 43, 29-34.

[33]   Deng, H.L. and Zhang, J.T. (1991) Anti-lipid peroxilative effect of ginsenoside Rb1 and Rg1. Chinese Medical Journal (English Edition), 104, 395-398.

[34]   Li, Y., Tu, L., Chen, D., Jiang, R., Wang, Y. and Wang, S. (2012) Study on functional recovery of hypoxic-ischemic brain injury by Rg1-induced NSCs. Zhongguo Zhong Yao Za Zhi, 37, 509-514.

[35]   Li, W.K., Ran, W.B., Su, Y.W. and Huang, F.J. (2008) Effects of ginsenoside Rg1 on expression of insulin-like growth factor-1 in brain of rats with brain contusion. Zhong Xi Yi Jie He Xue Bao, 6, 911-914.
http://dx.doi.org/10.3736/jcim20080907

[36]   Jin, L.Q. and Shi, L. (1991) Effects of saponins of Panax notoginseng on sodium-potassium-adenosine triphosphatase and calcium-magnesium-adenosine triphosphatase. Zhongguo Yao Li Xue Bao, 12, 504-506.

[37]   Liu, M. and Zhang, J.T. (1996) Effects of ginsenoside Rg1 on c-fos gene expression and cAMP levels in rat hippocampus. Zhongguo Yao Li Xue Bao, 17, 171-174.

[38]   Stancheva, S.L. and Alova, L.G. (1993) Ginsenoside Rg1 inhibits the brain cAMP phosphodiesterase activity in young and aged rats. General Pharmacology, 24, 14591462. http://dx.doi.org/10.1016/0306-3623(93)90435-Z

[39]   Wang, D., Huang, Y., Li, Q., Xu, S. and Liu, X. (2010) Anti-apoptotic effect of ginsenoside Rg1 on neuron after neonatal hypoxia ischemia brain damage. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 24, 1107-1112.

[40]   Liu, Z.J., Zhao, M., Zhang, Y., Xue, J.F. and Chen, N.H. (2010) Ginsenoside Rg1 promotes glutamate release via a calcium/calmodulin-dependent protein kinase II-dependent signaling pathway. Brain Research, 1333, 1-8.
http://dx.doi.org/10.1016/j.brainres.2010.03.096

[41]   Tang, B., Qu, Y., Wang, D. and Mu, D. (2011) Targeting hypoxia inducible factor-1α: A novel mechanism of ginsenoside Rg1 for brain repair afterhypoxia/ischemia brain damage. CNS & Neurological Disorders-Drug Targets, 10, 235-238.
http://dx.doi.org/10.2174/187152711794480456

[42]   Wang, D.J., Li, Q.Y., Xu, S.J. and Zeng, N. (2011) Effect of ginsenoside Rg1 on angiogenesis after neonatal hypoxia ischemia brain damage in rats. Sichuan Da Xue Xue Bao Yi Xue Ban, 42, 503-507.

[43]   Himi, T., Saito, H. and Nishiyama, N. (1989) Effect of ginseng saponins on the survival of cerebral cortex neurons in cell cultures. Chemical & Pharmaceutical Bulletin (Tokyo), 37, 481-484.
http://dx.doi.org/10.1248/cpb.37.481

[44]   Shen, L.H. and Zhang, J.T. (2003) Culture of neural stem cells from cerebral cortex of rat embryo and effects of drugs on the proliferation ability ofstem cells. Yao Xue Xue Bao, 38, 735-738.

[45]   Lu, Z.F., Shen, Y.X., Zhang, P., Xu, Y.J., Fan, Z.H., Cheng, M.H. and Dong, Q.R. (2010) Ginsenoside Rg1 promotes proliferation and neurotrophin expression of olfactory ensheathing cells. Journal of Asian Natural Products Research, 12, 265-272.
http://dx.doi.org/10.1080/10286021003689791

[46]   Shen, L. and Zhang, J. (2003) Ginsenoside Rg1 increases ischemia-induced cell proliferation and survival in the dentate gyrus of adult gerbils. Neuroscience Letters, 344, 1-4. http://dx.doi.org/10.1016/S0304-3940(03)00318-5

[47]   Shen, L.H. and Zhang, J.T. (2004) Ginsenoside Rg1 promotes proliferation of hippocampal progenitor cells. Neurological Research, 26, 422-428.
http://dx.doi.org/10.1179/016164104225016047

[48]   Chen, Z.Y., Du, T.M. and Chen, S.C. (2011) Effects of ginsenoside Rg1 on learning and memory function and morphology of hippocampal neurons of ratswith electrical hippocampal injuries. Nan Fang Yi Ke Da Xue Xue Bao, 31, 1039-1042.

[49]   Wang, L. and Kisaalita, W.S. (2011) Administration of BDNF/ginsenosides combination enhanced synaptic development in human neural stem cells. Journal of Neuroscience Methods, 194, 274-282.
http://dx.doi.org/10.1016/j.jneumeth.2010.10.025

[50]   Mook-Jung, I., Hong, H.S., Boo, J.H., Lee, K.H., Yun, S.H., Cheong, M.Y., Joo, I., Huh, K. and Jung, M.W. (2001) Ginsenoside Rb1 and Rg1 improve spatial learning and increase hippocampal synaptophysin level in mice. Journal of Neuroscience Methods, 63, 509-515.
http://dx.doi.org/10.1002/jnr.1045

[51]   Li, W.K., Ran, W.B., Su, Y.W. and Huang, F.J. (2008) Effects of ginsenoside Rg1 on expression of insulin-like growth factor-1 in brain of rats with brain contusion. Zhong Xi Yi Jie He Xue Bao, 6, 911-914.
http://dx.doi.org/10.3736/jcim20080907

[52]   Zhang, Y.G. and Liu, T.P. (1996) Influences of ginsenosides Rb1 and Rg1 on reversible focal brain ischemia in rats. Zhongguo Yao Li Xue Bao, 17, 44-48.

[53]   Zhang, Y.F., Fan, X.J., Li, X., Peng, L.L., Wang, G.H., Ke, K.F. and Jiang, Z.L. (2008) Ginsenoside Rg1 protects neurons from hypoxic-ischemic injury possibly by inhibiting Ca2+ influx through NMDAreceptors and L-type voltage-dependent Ca2+ channels. European Journal of Pharmacology, 586, 90-99.
http://dx.doi.org/10.1016/j.ejphar.2007.12.037

[54]   Liu, X., Xia, J., Wang, L., Song, Y., Yang, J., Yan, Y., Ren, H. and Zhao, G. (2009) Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: A randomized, doubleblind, placebo-controlled, phase II multicenter trial. European Journal of Neurology, 16, 569-575.
http://dx.doi.org/10.1111/j.1468-1331.2009.02534.x

[55]   Zhang, Y., Zhou, L., Zhang, X., Bai, J., Shi, M. and Zhao, G. (2012) Ginsenoside-Rd attenuates TRPM7 and ASIC1a but promotes ASIC2a expression in rats after focal cerebralischemia. Neurological Sciences, 33, 1125-1131.
http://dx.doi.org/10.1007/s10072-011-0916-6

[56]   Cai, B.X., Li, X.Y., Chen, J.H., Tang, Y.B., Wang, G.L., Zhou, J.G., Qui, Q.Y. and Guan, Y.Y. (2009) GinsenosideRd, a new voltage-independent Ca2+ entry blocker, reverses basilar hypertrophic remodeling instroke-prone renovascular hypertensive rats. European Journal of Pharmacology, 606, 142-149.
http://dx.doi.org/10.1016/j.ejphar.2009.01.033

[57]   Ye, R., Kong, X., Yang, Q., Zhang, Y., Han, J., Li, P., Xiong, L. and Zhao, G. (2011) Ginsenoside Rd in experimental stroke: Superior neuroprotective efficacy with a wide therapeutic window. Neurotherapeutics, 8, 515-525.
http://dx.doi.org/10.1007/s13311-011-0051-3

[58]   Ye, R., Yang, Q., Kong, X., Han, J., Zhang, X., Zhang, Y., Li, P., Liu, J., Shi, M., Xiong, L. and Zhao, G. (2011) Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focalischemia in rats. Neurochemistry International, 58, 391-398. http://dx.doi.org/10.1016/j.neuint.2010.12.015

[59]   Ye, R., Kong, X., Yang, Q., Zhang, Y., Han, J. and Zhao, G. (2011) Ginsenoside Rd attenuates redox imbalance and improves stroke outcome after focal cerebral ischemia in aged mice. Neuropharmacology, 61, 815-824.
http://dx.doi.org/10.1016/j.neuropharm.2011.05.029

[60]   Ye, R., Zhang, X., Kong, X., Han, J., Yang, Q., Zhang, Y., Chen, Y., Li, P., Liu, J., Shi, M., Xiong, L. and Zhao, G. (2011) Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia. Neuroscience, 178, 169-180.
http://dx.doi.org/10.1016/j.neuroscience.2011.01.007

[61]   Hu, G., Wu, Z., Yang, F., Zhao, H., Liu, X., Deng, Y., Shi, M. and Zhao, G. (2013) Ginsenoside Rd blocks AIF mitochondrio-nuclear translocation and NF-κB nuclear accumulation by inhibitingpoly(ADP-ribose) polymerase-1 after focal cerebral ischemia in rats. Neurological Sciences, 34, 2101-2106.
http://dx.doi.org/10.1007/s10072-013-1344-6

[62]   Ye, R., Li, N., Han, J., Kong, X., Cao, R., Rao, Z. and Zhao, G. (2009) Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons. Neuroscience Research, 64, 306-310.
http://dx.doi.org/10.1016/j.neures.2009.03.016

[63]   Lin, T., Liu, Y., Shi, M., Liu, X., Li, L., Liu, Y. and Zhao, G. (2012) Promotive effect of ginsenoside Rd on proliferation of neural stem cells in vivo and in vitro. Journal of Ethnopharmacology, 142, 754-761.
http://dx.doi.org/10.1016/j.jep.2012.05.057

[64]   Zhou, X.M., Cao, Y.L. and Dou, D.Q. (2006) Protective effect of ginsenoside-Re against cerebral ischemia/reperfusion damage in rats. Biological and Pharmaceutical Bulletin, 29, 2502-2505.
http://dx.doi.org/10.1248/bpb.29.2502

[65]   Chen, L.M., Zhou, X.M., Cao, Y.L. and Hu, W.X. (2008) Neuroprotection of ginsenoside Re in cerebral ischemiareperfusion injury in rats. Journal of Asian Natural Products Research, 10, 439-445.
http://dx.doi.org/10.1080/10286020801892292

[66]   Gu, B., Nakamichi, N., Zhang, W.S., Nakamura, Y., Kambe, Y., Fukumori, R., Takuma, K., Yamada, K., Takarada, T., Taniura, H. and Yoneda, Y. (2009) Possible protection by notoginsenoside R1 against glutamate neurotoxicity mediated by N-methyl-D-aspartatereceptors composed of an NR1/NR2B subunit assembly. Journal of Neuroscience Research, 87, 2145-2156.
http://dx.doi.org/10.1002/jnr.22021

[67]   Hunter, A.J., Mackay, K.B. and Rogers, D.C. (1998) To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents? Trends in Pharmacological Sciences, 19, 59-66. http://dx.doi.org/10.1016/S0165-6147(97)01157-7

[68]   Hossmann, K.A. (1991) Animal models of cerebral ischemia, 1: Review of literature. Cerebrovascular Diseases, 1, 2-15.

 
 
Top